Literature DB >> 18272826

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Elizabeth T Rosolowsky1, Linda H Ficociello, Nicholas J Maselli, Monika A Niewczas, Amanda L Binns, Bijan Roshan, James H Warram, Andrzej S Krolewski.   

Abstract

BACKGROUND AND OBJECTIVES: Early renal function decline begins before the onset of proteinuria in patients with type 1 diabetes. The association of elevated serum uric acid with advanced impaired renal function prompts an examination of its role in early renal function decline in patients before proteinuria develops. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with type 1 diabetes and normoalbuminuria or microalbuminuria were recruited to the Second Joslin Kidney Study. A medical history and measurements of BP, hemoglobin A1c, albumin excretion rate, and serum concentrations of uric acid and cystatin C were obtained. Estimated glomerular filtration rate was measured by a cystatin C-based formula.
RESULTS: We studied 364 patients with normoalbuminuria and 311 patients with microalbuminuria. Mean glomerular filtration rate in these groups was 119 and 99 ml/min, respectively. Mildly or moderately impaired renal function (<90 ml/min) was present in 10% of those with normoalbuminuria and 36% of those with microalbuminuria. In univariate and multivariate analyses, lower glomerular filtration rate was strongly and independently associated with higher serum uric acid and higher urinary albumin excretion rate, older age, and antihypertensive treatment.
CONCLUSIONS: Serum uric acid concentration in the high-normal range is associated with impaired renal function in patients with type 1 diabetes. Follow-up studies are needed to confirm that this level of serum uric acid is a risk factor for early renal function decline in type 1 diabetes and to determine whether its reduction would prevent the decline.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272826      PMCID: PMC2386694          DOI: 10.2215/CJN.04271007

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  41 in total

1.  Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance.

Authors:  G D Tan; A V Lewis; T J James; P Altmann; R P Taylor; J C Levy
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

2.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Authors:  Duk-Hee Kang; Sung-Kwang Park; In-Kyu Lee; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

3.  Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

4.  Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion.

Authors:  P H Lane; M W Steffes; S M Mauer
Journal:  Diabetes       Date:  1992-05       Impact factor: 9.461

Review 5.  Aging and the kidney.

Authors:  M Epstein
Journal:  J Am Soc Nephrol       Date:  1996-08       Impact factor: 10.121

6.  Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions.

Authors:  M Luiza Caramori; Paola Fioretto; Michael Mauer
Journal:  Diabetes       Date:  2003-04       Impact factor: 9.461

7.  Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.

Authors:  Johan Sundström; Lisa Sullivan; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Hypertension       Date:  2004-11-29       Impact factor: 10.190

8.  Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

Authors:  M Krolewski; P W Eggers; J H Warram
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

9.  Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio.

Authors:  J H Warram; G Gearin; L Laffel; A S Krolewski
Journal:  J Am Soc Nephrol       Date:  1996-06       Impact factor: 10.121

10.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

View more
  61 in total

1.  Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

Authors:  Tomohito Gohda; William H Walker; Pawel Wolkow; Jung Eun Lee; James H Warram; Andrzej S Krolewski; Monika A Niewczas
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

Review 2.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 3.  SLC2A9--a fructose transporter identified as a novel uric acid transporter.

Authors:  Myphuong T Le; Mohamed Shafiu; Wei Mu; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2008-07-07       Impact factor: 5.992

Review 4.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

5.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

Review 6.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

7.  Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

Authors:  Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; William Walker; Elizabeth T Rosolowsky; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 8.237

8.  Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

Authors:  Hirofumi Yano; Yoshifuru Tamura; Kana Kobayashi; Masayuki Tanemoto; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

Review 9.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

10.  Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients.

Authors:  Giacomo Zoppini; Giovanni Targher; Carlo Negri; Vincenzo Stoico; Fabrizia Perrone; Michele Muggeo; Enzo Bonora
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.